The Food and Drug Administration issued a warning letter to Amazon regarding the sale of unapproved herpes treatments. The agency purchased several products from Amazon’s website and identified numerous violations. These products were deemed unapproved new drugs, raising a serious public health concern due to potential delays in appropriate medical care and increased risk of severe complications like infertility, sepsis, and death. Reliance on these products may also lead to undetected transmission of infections.
The listed products include FemiClear, Hclear for him, HerpCare Ointment, HerpCare Spray, Herstat GST, Genital Herpes Ointment, RoyceDerm Herpes Relief Cream, Terragen HG Formula, and Genital Herpes Intimate Wash. The FDA noted that many products are labeled as homeopathic, but are still considered drugs and not exempt from approval requirements. Some products contain lemongrass, which is not listed in the Homeopathic Pharmacopeia of the United States. The FDA has not approved any over-the-counter treatments for sexually transmitted infections. Previous warnings have been issued to Amazon regarding other products, including potent chemical peels and energy-enhancing supplements, highlighting concerns about product safety and efficacy. Strong enforcement of regulatory standards is essential to ensure consumer protection and maintain confidence in nonprescription medicines, according to industry experts.